Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Wilder

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 28, 2001
Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatmentC E Pelloski, R B Wilder, C S Ha, et al.
Cancer|September 26, 2001
Hematologic recovery after central lymphatic irradiation for patients with stage I-III follicular lymphomaC S Ha, S L Tucker, A I Blanco, et al.
Cancer|June 20, 2001
Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphomaR B Wilder, M A Rodriguez, C S Ha, et al.
Cancer|March 10, 2001
Localized non-Hodgkin lymphoma involving the thyroid glandC S Ha, K M Shadle, L J Medeiros, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1997
Localization of the prostatic apex for radiotherapy treatment planning using urethroscopyR B Wilder, P D Fone, D E Rademacher, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Pterygium treated with excision and postoperative beta irradiationR B Wilder, J M Buatti, J M Kittelson, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2001
Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapyR B Wilder, S L Tucker, C S Ha, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2001
Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomasR B Wilder, M A Rodriguez, S L Tucker, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1994
The hypoxic cytotoxin SR 4233 increases the effectiveness of radioimmunotherapy in mice with human non-Hodgkin's lymphoma xenograftsR B Wilder, J K McGann, W R Sutherland, et al.
American Journal of Clinical Oncology|August 24, 2000
Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: preliminary resultsR B Wilder, R H Chou, J K Ryu, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 28, 2001
Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatmentC E Pelloski, R B Wilder, C S Ha, et al.
Cancer|September 26, 2001
Hematologic recovery after central lymphatic irradiation for patients with stage I-III follicular lymphomaC S Ha, S L Tucker, A I Blanco, et al.
Cancer|June 20, 2001
Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphomaR B Wilder, M A Rodriguez, C S Ha, et al.
Cancer|March 10, 2001
Localized non-Hodgkin lymphoma involving the thyroid glandC S Ha, K M Shadle, L J Medeiros, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1997
Localization of the prostatic apex for radiotherapy treatment planning using urethroscopyR B Wilder, P D Fone, D E Rademacher, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Pterygium treated with excision and postoperative beta irradiationR B Wilder, J M Buatti, J M Kittelson, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2001
Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapyR B Wilder, S L Tucker, C S Ha, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2001
Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomasR B Wilder, M A Rodriguez, S L Tucker, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1994
The hypoxic cytotoxin SR 4233 increases the effectiveness of radioimmunotherapy in mice with human non-Hodgkin's lymphoma xenograftsR B Wilder, J K McGann, W R Sutherland, et al.
American Journal of Clinical Oncology|August 24, 2000
Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: preliminary resultsR B Wilder, R H Chou, J K Ryu, et al.
Pageof 4